The mechanism of catalysis by type-II NADH:quinone oxidoreductases

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Blaza, James N ^a   Bridges, Hannah R ^a   Aragão, David ^b   Dunn, Elyse A ^c   Heikal, Adam ^c,d   Cook, Gregory M ^c,d   Nakatani, Yoshio ^c,d   Hirst, Judy ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b AUSTRALIAN SYNCHROTRON   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

4,6-DINITRO-O-CRESOL; DINITRO ORTHO CRESOL; PROTEIN BINDING; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE);

BACILLALES; BINDING SITE; CATALYSIS; CHEMISTRY; KINETICS; METABOLISM;

BACILLALES; BINDING SITES; CATALYSIS; DINITROCRESOLS; KINETICS; PROTEIN BINDING; QUINONE REDUCTASES; REACTIVE OXYGEN SPECIES;

EID: 85008932630     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40165     Document Type: Article

References (40)

1. Melo, A. M. P., Bandeiras, T. M. & Teixeira, M. New Insights into Type II NAD(P)H: quinone oxidoreductases. Microbiol. Mol. Biol. Rev. 68, 603-616 (2004).
2. Marreiros, B. C., Sena, F. V., Sousa, F. M., Batista, A. P. & Pereira, M. M. Type II NADH:quinone oxidoreductase family: phylogenetic distribution, structural diversity and evolutionary divergences. Environ. Microbiol (2016) in press.
3. Bai, Y. et al. Lack of complex I activity in human cells carrying a mutation in mtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) Gene. J. Biol. Chem. 276, 38808-38813 (2001).
4. Seo, B. B. et al. Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc. Natl. Acad. Sci. USA 95, 9167-9171 (1998).
5. Seo, B. B., Marella, M., Yagi, T. & Matsuno-Yagi, A. The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I. FEBS Lett. 580, 6105-6108 (2006).
6. Sanz, A. et al. Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restriction. Proc. Natl. Acad. Sci. USA 107, 9105-9110 (2010).
7. Griffin, J. E. et al. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7, 1-9 (2011).
8. Weinstein, E. A. et al. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proc. Natl. Acad. Sci. USA 102, 4548-4553 (2005).
9. Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S. & Rubin, H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). J. Biol. Chem. 281, 11456-63 (2006).
10. Warman, A. J. et al. Antitubercular pharmacodynamics of phenothiazines. J. Antimicrob. Chemother. 68, 869-880 (2013).
11. Dunn, E. A. et al. Incorporation of triphenylphosphonium functionality improves the inhibitory properties of phenothiazine derivatives in Mycobacterium tuberculosis. Bioorganic Med. Chem. 22, 5320-5328 (2014).
12. Iwata, M. et al. The structure of the yeast NADH dehydrogenase (Ndi1) reveals overlapping binding sites for water-and lipid-soluble substrates. Proc. Natl. Acad. Sci. USA 109, 15247-52 (2012).
13. Feng, Y. et al. Structural insight into the type-II mitochondrial NADH dehydrogenases. Nature 491, 478-82 (2012).
14. Heikal, A. et al. Structure of the bacterial type II NADH dehydrogenase: A monotopic membrane protein with an essential role in energy generation. Mol. Microbiol. 91, 950-64 (2014).
15. Sena, F. V. et al. Type-II NADH:quinone oxidoreductase from Staphylococcus aureus has two distinct binding sites and is rate limited by quinone reduction. Mol. Microbiol. 98, 272-288 (2015).
16. Velázquez, I. & Pardo, J. P. Kinetic characterization of the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Arch. Biochem. Biophys. 389, 7-14 (2001).
17. Eschemann, A., Galkin, A., Oettmeier, W., Brandt, U. & Kerscher, S. HDQ (1-hydroxy-2-dodecyl-4(1H)quinolone), a high affinity inhibitor for mitochondrial alternative NADH dehydrogenase: evidence for a ping-pong mechanism. J. Biol. Chem. 280, 3138-3142 (2005).
18. Yamashita, T., Nakamaru-Ogiso, E., Miyoshi, H., Matsuno-Yagi, A. & Yagi, T. Roles of bound quinone in the single subunit NADHquinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae. J. Biol. Chem. 282, 6012-6020 (2007).
19. Lin, S. S. et al. The Toxoplasma gondii type-II NADH dehydrogenase TgNDH2-I is inhibited by 1-hydroxy-2-alkyl-4(1H)quinolones. Biochim. Biophys. Acta 1777, 1455-1462 (2008).
20. Yano, T. et al. Mycobacterium tuberculosis type II NADH-menaquinone oxidoreductase catalyzes electron transfer through a two-site ping-pong mechanism and has two quinone-binding sites. Biochemistry 53, 1179-1190 (2014).
21. Yang, Y. et al. Reaction mechanism of single subunit NADH-ubiquinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae: evidence for a ternary complex mechanism. J. Biol. Chem. 286, 9287-97 (2011).
22. Salewski, J. et al. Substrate-protein interactions of Type II NADH:quinone oxidoreductase from Escherichia coli. Biochemistry 55, 2722-2734 (2016).
23. Desplats, C. et al. Modification of substrate specificity in single point mutants of Agrobacterium tumefaciens type II NADH dehydrogenase. FEBS Lett. 581, 4017-4022 (2007).
24. Berkholz, D. S., Faber, H. R., Savvides, S. N. & Karplus, P. A. Catalytic cycle of human glutathione reductase near 1 Å resolution. J. Mol. Biol. 382, 371-384 (2008).
25. Lee, K. H., Humbarger, S., Bahnvadia, R., Sazinsky, M. H. & Crane, E. J. Characterization of the mechanism of the NADH-dependent polysulfide reductase (Npsr) from Shewanella loihica PV-4: Formation of a productive NADH-enzyme complex and its role in the general mechanism of NADH and FAD-dependent enzymes. Biochim. Biophys. Acta 1844, 1708-1717 (2014).
26. Kussmaul, L. & Hirst, J. The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc. Natl. Acad. Sci. USA 103, 7607-12 (2006).
27. Yakovlev, G. & Hirst, J. Transhydrogenation reactions catalyzed by mitochondrial NADH-ubiquinone oxidoreductase (complex I). Biochemistry 46, 14250-14258 (2007).
28. Cook, P. & Cleland, W. Enzyme Kinetics and Mechanism (Garland Science, 2007).
29. Mogi, T. et al. Identification of new inhibitors for alternative NADH dehydrogenase (NDH-II). FEMS Microbiol. Lett. 291, 157-161 (2009).
30. Shirude, P. S. et al. Quinolinyl pyrimidines: potent inhibitors of NDH-2 as a novel class of anti-TB agents. ACS Med. Chem. Lett. 3, 736-740 (2012).
31. Pidathala, C. et al. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2). J. Med. Chem. 55, 1831-1843 (2012).
32. Deris, Z. Z. et al. A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADHquinone oxidoreductase activity. J. Antibiot. 67, 147-151 (2014).
33. Amaral, L., Kristiansen, J. E., Viveiros, M. & Atouguia, J. Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: A review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy. J. Antimicrob. Chemother. 47, 505-511 (2001).
34. Liu, H. & Naismith, J. H. An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8, 91 (2008).
35. Miroux, B. & Walker, J. E. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J. Mol. Biol. 260, 289-298 (1996).
36. Kabsch, W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 66, 125-32 (2010).
37. Collaborative Computational Project, N. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. Biol. Crystallogr. 50, 760-3 (1994).
38. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
39. Adams, P. D. et al. PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr. Sect. D Biol. Crystallogr. 58, 1948-1954 (2002).
40. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 486-501 (2010).